Clinical Trial Update: First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib [Phase 2]

View source ↗

Summary

Phase 2 study evaluating first-line treatment of metastatic colorectal cancer using mFOLFOX6 in combination with regorafenib; the trial has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)
• mFOLFOX6 regimen

Snippet

Sponsor: Bayer | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-09-04